The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Foster Jonathan P.

Reporting owner CIK 0001545414 · Chief Financial Officer

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Foster Jonathan P.Foster Jonathan P.Foster Jonathan P. · October 15, 2026 · Stock award · Restricted Stock UnitsFoster Jonathan P. · October 15, 2026 · Stock award · Stock Options (right to buy)Foster Jonathan P. · October 15, 2026 · Exercise / conversion · Common StockFoster Jonathan P. · November 12, 2025 · Stock award · Performance Based Restricted Stock UnitsFoster Jonathan P. · November 12, 2025 · Stock award · Stock option (right to buy)Foster Jonathan P. · November 4, 2025 · Exercise / conversion · Common StockNov 4, 2025Oct 15, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

6 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 15, 2026Moleculin Biotech, Inc.Restricted Stock UnitsFoster Jonathan P.Stock award
Oct 15, 2026Moleculin Biotech, Inc.Stock Options (right to buy)Foster Jonathan P.Stock award
Oct 15, 2026Moleculin Biotech, Inc.Common StockFoster Jonathan P.Exercise / conversion
Nov 12, 2025Moleculin Biotech, Inc.Performance Based Restricted Stock UnitsFoster Jonathan P.Stock award
Nov 12, 2025Moleculin Biotech, Inc.Stock option (right to buy)Foster Jonathan P.Stock award
Nov 4, 2025Moleculin Biotech, Inc.Common StockFoster Jonathan P.Exercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Moleculin Biotech, Inc.MBRX · company listings
Foster Jonathan P.Chief Financial Officer
Stock awardRestricted Stock UnitsDerivative security · Code A260,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Moleculin Biotech, Inc.MBRX · company listings
Foster Jonathan P.Chief Financial Officer
Stock awardStock Options (right to buy)Derivative security · Code A260,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Moleculin Biotech, Inc.MBRX · company listings
Foster Jonathan P.Chief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M130,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Moleculin Biotech, Inc.MBRX · company listingsStock awardPerformance Based Restricted Stock UnitsDerivative security · Code A400,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Moleculin Biotech, Inc.MBRX · company listingsStock awardStock option (right to buy)Derivative security · Code A600,000Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Moleculin Biotech, Inc.MBRX · company listings
Foster Jonathan P.Chief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M20,625Not reported *Value: Not reportedCurrency not specifiedView ↗